In the immune microenvironment of gastric cancer, the phosphoinositide 3-kinase (PI3K)-protein kinase B (AKT)-mammalian target of rapamycin (mTOR) pathway is abnormally activated, which stimulates the abnormal proliferation of malignant tumors. This evidence concerns the gene AKT1 and gastric cancer.